Abstract

Gender medicine explores how sex differences influence the onset, progression, and perception of specific diseases.  In the case of ADPKD, female sex seems to impact various aspects of the condition. Women with ADPKD may experience a different progression of the disease compared to men, with a higher predisposition to developing certain complications such as polycystic liver disease, which can have a range of clinical consequences of varying severity. Perception and subjective experience of the disease can also vary significantly, affecting emotional well-being and quality of life.
Pregnancy, for instance, represents a critical phase for women with ADPKD, requiring specialized monitoring and specific management to address potential complications. Genetic counseling is essential for providing informational support and helping families understand the hereditary implications of the disease. Modern pre-implantation diagnostic techniques also allow for the identification of the disease before birth, improving family planning and reducing the risk of transmission.
Another important aspect is hormonal therapy, which was previously excluded in women with ADPKD due to concerns about potential effects on the growth of hepatic cysts. However, with advances in knowledge and increasing attention to specific needs, a targeted individual approach to hormonal therapy may prove beneficial, offering new therapeutic opportunities.
Looking ahead, it is desirable for gender medicine to continue evolving, leading to increasingly personalized disease management and optimized care, with a positive impact on the overall well-being of individual patients.

Keywords: ADPKD, polycystic kidney disease, gender medicine